1. Van Dyke T, Jacks T. Cancer modelling in the modern era: progress and challenges. Cell. 2002;108:135–44.
2. Grever M, Chaner BA. The National Cancer Institute: Cancer drug discovery and development program. In: (DeVita VT, Jr., Hellman S, Rosenberg SA, eds.). Cancer principles & practice of oncology. (5th ed). Philadelphia (PA): Lippincott-Raven; 1997.
3. DeVita Jr VT, Hellman S, Rosenberg SA (eds.). Cancer: Principles and Practice of Oncology. 7th. Ed. Lippincott Williams & Wilkins. 2005; p. 3120.
4. Ruoslahti E. Fibronectin and its integrin receptors in cancer. Adv Cancer Res. 1999;76:1–20.
5. Weber GF (ed.): Cancer Therapy: Molecular Targets in Tumor-Host Interactions. Horizon Bioscience. Editor University of Cincinnati Medical Center, Cincinnati, OH, USA. 2005; p. 398.